Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI)

David G. Kiely; David L. Levin; Paul M. Hassoun; Dunbar Ivy; Pei Ni Jone; Jumaa Bwika; Steven M. Kawut; Jim Lordan; Angela Lungu; Jeremy A. Mazurek; Shahin Moledina; Horst Olschewski; Andrew J. Peacock; G. D. Puri; Farbod N. Rahaghi; Michal Schafer; Mark Schiebler; Nicholas Screaton; Merryn Tawhai; Edwin J.R. van Beek; Anton Vonk-Noordegraaf; Rebecca Vandepool; Stephen J. Wort; Lan Zhao; Jim M. Wild; Jens Vogel-Claussen; Andrew J. Swift

doi:10.1177/2045894019841990

Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI)

David G. Kiely, David L. Levin, Paul M. Hassoun, Dunbar Ivy, Pei Ni Jone, Jumaa Bwika, Steven M. Kawut, Jim Lordan, Angela Lungu, Jeremy A. Mazurek, Shahin Moledina, Horst Olschewski, Andrew J. Peacock, G. D. Puri, Farbod N. Rahaghi, Michal Schafer, Mark Schiebler, Nicholas Screaton, Merryn Tawhai, Edwin J.R. van BeekAnton Vonk-Noordegraaf, Rebecca Vandepool, Stephen J. Wort, Lan Zhao, Jim M. Wild, Jens Vogel-Claussen, Andrew J. Swift

School of Medicine

Research output: Contribution to journal › Article › peer-review

31 Scopus citations

Abstract

Pulmonary hypertension (PH) is highly heterogeneous and despite treatment advances it remains a life-shortening condition. There have been significant advances in imaging technologies, but despite evidence of their potential clinical utility, practice remains variable, dependent in part on imaging availability and expertise. This statement summarizes current and emerging imaging modalities and their potential role in the diagnosis and assessment of suspected PH. It also includes a review of commonly encountered clinical and radiological scenarios, and imaging and modeling-based biomarkers. An expert panel was formed including clinicians, radiologists, imaging scientists, and computational modelers. Section editors generated a series of summary statements based on a review of the literature and professional experience and, following consensus review, a diagnostic algorithm and 55 statements were agreed. The diagnostic algorithm and summary statements emphasize the key role and added value of imaging in the diagnosis and assessment of PH and highlight areas requiring further research.

Original language	English (US)
Journal	Pulmonary Circulation
Volume	9
Issue number	3
DOIs	https://doi.org/10.1177/2045894019841990
State	Published - Jul 2019

Keywords

algorithm
cardiac catheterization
computed tomography
diagnosis
echocardiography
guidelines
imaging
magnetic resonance imaging
pulmonary hypertension

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine

Access to Document

10.1177/2045894019841990

Cite this

Kiely, D. G., Levin, D. L., Hassoun, P. M., Ivy, D., Jone, P. N., Bwika, J., Kawut, S. M., Lordan, J., Lungu, A., Mazurek, J. A., Moledina, S., Olschewski, H., Peacock, A. J., Puri, G. D., Rahaghi, F. N., Schafer, M., Schiebler, M., Screaton, N., Tawhai, M., ... Swift, A. J. (2019). Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI). Pulmonary Circulation, 9(3). https://doi.org/10.1177/2045894019841990

Kiely, DG, Levin, DL, Hassoun, PM, Ivy, D, Jone, PN, Bwika, J, Kawut, SM, Lordan, J, Lungu, A, Mazurek, JA, Moledina, S, Olschewski, H, Peacock, AJ, Puri, GD, Rahaghi, FN, Schafer, M, Schiebler, M, Screaton, N, Tawhai, M, van Beek, EJR, Vonk-Noordegraaf, A, Vandepool, R, Wort, SJ, Zhao, L, Wild, JM, Vogel-Claussen, J & Swift, AJ 2019, 'Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI)', Pulmonary Circulation, vol. 9, no. 3. https://doi.org/10.1177/2045894019841990

@article{60fa8f855c624873b6b5936200fd0936,

title = "Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI)",

abstract = "Pulmonary hypertension (PH) is highly heterogeneous and despite treatment advances it remains a life-shortening condition. There have been significant advances in imaging technologies, but despite evidence of their potential clinical utility, practice remains variable, dependent in part on imaging availability and expertise. This statement summarizes current and emerging imaging modalities and their potential role in the diagnosis and assessment of suspected PH. It also includes a review of commonly encountered clinical and radiological scenarios, and imaging and modeling-based biomarkers. An expert panel was formed including clinicians, radiologists, imaging scientists, and computational modelers. Section editors generated a series of summary statements based on a review of the literature and professional experience and, following consensus review, a diagnostic algorithm and 55 statements were agreed. The diagnostic algorithm and summary statements emphasize the key role and added value of imaging in the diagnosis and assessment of PH and highlight areas requiring further research.",

keywords = "algorithm, cardiac catheterization, computed tomography, diagnosis, echocardiography, guidelines, imaging, magnetic resonance imaging, pulmonary hypertension",

author = "Kiely, {David G.} and Levin, {David L.} and Hassoun, {Paul M.} and Dunbar Ivy and Jone, {Pei Ni} and Jumaa Bwika and Kawut, {Steven M.} and Jim Lordan and Angela Lungu and Mazurek, {Jeremy A.} and Shahin Moledina and Horst Olschewski and Peacock, {Andrew J.} and Puri, {G. D.} and Rahaghi, {Farbod N.} and Michal Schafer and Mark Schiebler and Nicholas Screaton and Merryn Tawhai and {van Beek}, {Edwin J.R.} and Anton Vonk-Noordegraaf and Rebecca Vandepool and Wort, {Stephen J.} and Lan Zhao and Wild, {Jim M.} and Jens Vogel-Claussen and Swift, {Andrew J.}",

note = "Funding Information: This study was supported by the Wellcome Trust [R/148654-11-1]. Publisher Copyright: {\textcopyright} The Author(s) 2019.",

year = "2019",

month = jul,

doi = "10.1177/2045894019841990",

language = "English (US)",

volume = "9",

journal = "Pulmonary Circulation",

issn = "2045-8932",

publisher = "University of Chicago Press",

number = "3",

}

TY - JOUR

T1 - Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI)

AU - Kiely, David G.

AU - Levin, David L.

AU - Hassoun, Paul M.

AU - Ivy, Dunbar

AU - Jone, Pei Ni

AU - Bwika, Jumaa

AU - Kawut, Steven M.

AU - Lordan, Jim

AU - Lungu, Angela

AU - Mazurek, Jeremy A.

AU - Moledina, Shahin

AU - Olschewski, Horst

AU - Peacock, Andrew J.

AU - Puri, G. D.

AU - Rahaghi, Farbod N.

AU - Schafer, Michal

AU - Schiebler, Mark

AU - Screaton, Nicholas

AU - Tawhai, Merryn

AU - van Beek, Edwin J.R.

AU - Vonk-Noordegraaf, Anton

AU - Vandepool, Rebecca

AU - Wort, Stephen J.

AU - Zhao, Lan

AU - Wild, Jim M.

AU - Vogel-Claussen, Jens

AU - Swift, Andrew J.

PY - 2019/7

Y1 - 2019/7

N2 - Pulmonary hypertension (PH) is highly heterogeneous and despite treatment advances it remains a life-shortening condition. There have been significant advances in imaging technologies, but despite evidence of their potential clinical utility, practice remains variable, dependent in part on imaging availability and expertise. This statement summarizes current and emerging imaging modalities and their potential role in the diagnosis and assessment of suspected PH. It also includes a review of commonly encountered clinical and radiological scenarios, and imaging and modeling-based biomarkers. An expert panel was formed including clinicians, radiologists, imaging scientists, and computational modelers. Section editors generated a series of summary statements based on a review of the literature and professional experience and, following consensus review, a diagnostic algorithm and 55 statements were agreed. The diagnostic algorithm and summary statements emphasize the key role and added value of imaging in the diagnosis and assessment of PH and highlight areas requiring further research.

AB - Pulmonary hypertension (PH) is highly heterogeneous and despite treatment advances it remains a life-shortening condition. There have been significant advances in imaging technologies, but despite evidence of their potential clinical utility, practice remains variable, dependent in part on imaging availability and expertise. This statement summarizes current and emerging imaging modalities and their potential role in the diagnosis and assessment of suspected PH. It also includes a review of commonly encountered clinical and radiological scenarios, and imaging and modeling-based biomarkers. An expert panel was formed including clinicians, radiologists, imaging scientists, and computational modelers. Section editors generated a series of summary statements based on a review of the literature and professional experience and, following consensus review, a diagnostic algorithm and 55 statements were agreed. The diagnostic algorithm and summary statements emphasize the key role and added value of imaging in the diagnosis and assessment of PH and highlight areas requiring further research.

KW - algorithm

KW - cardiac catheterization

KW - computed tomography

KW - diagnosis

KW - echocardiography

KW - guidelines

KW - imaging

KW - magnetic resonance imaging

KW - pulmonary hypertension

UR - http://www.scopus.com/inward/record.url?scp=85071787039&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071787039&partnerID=8YFLogxK

U2 - 10.1177/2045894019841990

DO - 10.1177/2045894019841990

M3 - Article

C2 - 30880632

AN - SCOPUS:85071787039

SN - 2045-8932

VL - 9

JO - Pulmonary Circulation

JF - Pulmonary Circulation

IS - 3

ER -

Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI)

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this